SEC Form 4 · accession 0001179110-16-018108
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliott B Grossbard
Officer — EVP, CMO
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 6:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.74 | Jan 26, 2016 | A | 150,000 | A | — | Jan 26, 2026 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The shares vest monthly over two (2) years from January 1, 2016.